Emergency authorisation of Covid-19 vaccines needs great care: WHO
Although every country had the right to approve drugs without full trial, “it is not something that you do lightly”, WHO chief scientist Soumya Swaminathan told a news conference
FILE PHOTO: A handout photo provided by the Russian Direct Investment Fund (RDIF) shows samples of a vaccine against the coronavirus disease (Covid-19) developed by the Gamaleya Research Institute of Epidemiology and Microbiology, in Moscow, Russia August 6, 2020. The Russian Direct Investment Fund (RDIF)/Handout via REUTERS
The emergency authorisation of Covid-19 vaccines requires a "great deal of seriousness and reflection", the World Health Organization said on Monday.
Although every country had the right to approve drugs without full trial, "it is not something that you do lightly", WHO chief scientist Soumya Swaminathan told a news conference.
Keep updated, follow The Business Standard's Google news channel
